ClinicalTrials.gg
RecruitingNCT07727408Updated Jul 27, 2026

Management of Early Onset Scoliosis by Active Apex Correction Technique

An interventional study of Active Apex correction of scoliotic deformity in Cases of Early Onset Scoliosis, sponsored by Al-Azhar University. Recruiting at 1 site in Egypt. Open to participants aged 1 Year to 10 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Nov 2023; still recruiting 2 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
1 Year to 10 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 31 studies in Scoliosis with a site in Egypt — 9 open to participants now, 12 under way, none of them phase 3. Scoliosis · Egypt.

Planned enrollment
16th of 17
15 · median 40
Started
2023
with 5 others
No phase
16 of 31
6 open now
Primary completion
2026-10
later than 7 of 11 live
Registered
12th of 31
by date
Lead sponsor
1 of 31
Al-Azhar University

Among the 31 studies in Scoliosis with a site in Egypt, this one is the 16th largest by planned enrollment of the 17 interventional ones that give a count, is one of 6 that started in 2023, is one of 16 with no phase, reaches primary completion later than 7 of the 11 other live ones, and was the 12th registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.

Browse Scoliosis studies →

Open to participants now

9 of the 31 studies in Scoliosis with a site in Egypt are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 1 Year to 10 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies in Scoliosis with a site in Egypt, or all of them as a file.
02

Study summary

Early onset scoliosis is challenging cases in management .different techniques used to correct the deformity ranging between fusionlees and fusion surgery. Fusionless surgery permits developments of vertebral column and lung to avoid thoracic insufficiency syndrome. Fusion surgeries for complicated and high curves .New fusionless technique that I will use in my research is to modulate and guide the growth of the Apex of deformity through tethering the convex side and modulate the concave side and follow up the patients to see the results on their radiological and clinical parameters.

03

Conditions studied

  • Cases of Early Onset Scoliosis

Browse trials for

04

Who can participate

Ages eligible
1 Year to 10 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients with early-onset scoliosis below 10 years
  • patients not operated on before.

Exclusion criteria

Exclusion Criteria:

  • Patients above 10 years.
  • Patients operated on before
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Surgery

    Procedure: Active Apex correction of scoliotic deformity

Interventions

  • ProcedureActive Apex correction of scoliotic deformity

    Tethering the convex side of Apex and modulation of the concave side .proximal and distal anchoring screws. Dominos between rods to slide and permits the growth of the vertebral column

06

What researchers measure

Primary outcomes

  1. Change in major coronal Cobb angle

    Radiographic correction of the primary scoliotic curve measured as the change in the major coronal Cobb angle (degrees) on standing posteroanterior whole-spine radiographs

    Time frame: Baseline to 12 months after Active Apex Correction (APC) surgery

Secondary outcomes

  1. Change in thoracic spinal growth

    Change in T1-T12 spinal height (mm) measured on standing whole-spine radiographs.

    Time frame: Baseline to 12 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Related links

Individual participant data

Plan to share: No — Contact through my phone number or my email

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2023 (actual). Primary completion is estimated for Oct 2026, 34 months after the start.

Of 224 non-industry interventional studies with no phase under Scoliosis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 58. This study's planned 34 months is above that.

Counting every sponsor, half of 234 studies reached it within 22 months; a quarter within 8 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 19, 2023
First posted
Jul 27, 2026
StartActual
Nov 25, 2023
Primary completionEst.
Oct 11, 2026
CompletionEst.
Jan 2, 2027
Last update
Jul 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07727408
Responsible party
Mahmoud Gaber Elsayed (Assistant Lecturer of Orthopedic Surgery of Alazahr University assuit branch, Al-Azhar University) — Principal investigator
First posted
Jul 27, 2026
Start date
Nov 25, 2023
Primary completion
Oct 11, 2026 (estimated)
Completion
Jan 2, 2027 (estimated)
Last update
Jul 27, 2026

Study contacts

mahmoud gaber
Contact
mahmoudgaber300@gmail.com
+201094189506

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion